EquityFlow
›
Companies
› Flindr Therapeutics
Flindr Therapeutics
Biotech
· NL
Precision oncology small-molecule developer.
Funding history
Date
Round
Amount
Apr 2024
Series A
Flindr Therapeutics, a Dutch precision-oncology biotech, raised a EUR20M Series A led by V-Bio Ventures.
$21.6M
Investors
Curie Capital
Flanders Future Tech Fund
Johnson & Johnson Innovation
QBIC fund
V-Bio Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →